MSOR5 Presentation Time: 5:20 PM: 5-aminoleuvonic Acid (5-ALA) Use with Concurrent Intraoperative Radiotherapy: Interim Analysis of the INTRAGO II Trial for Glioblastoma

Autor: Cifarelli, Christopher P., Petrecca, Kevin, Kahl, Henning, Ganslandt, Oliver, Abdelrhman, Tamer, Combs, Stephanie, Sarria, Gustavo, Giordano, Frank A.
Zdroj: In Brachytherapy November-December 2024 23(6) Supplement:S37-S38
Databáze: ScienceDirect